Causes of sensitisation in patients awaiting renal transplantation in Ireland

Irish Medical Journal

Volumn 96, Issue 4, 2003, Pages 109-112

  Soosay, A ^a   O'Neill, D ^a   Counihan, A ^a   Hickey, D ^a   Keogan, Mary ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HLA ANTIGEN; ALLOANTIBODY;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; IRELAND; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREGNANCY; RETROSPECTIVE STUDY; SENSITIZATION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TRANSFUSION; BLOOD TRANSFUSION; HISTOCOMPATIBILITY TEST; IMMUNOLOGY;

BLOOD TRANSFUSION; FEMALE; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; RETROSPECTIVE STUDIES;

EID: 0038488183     PISSN: 03323102     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Wolfe RA, Ashby VB, Milford EL et al., Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation and recipients of a first cadaveric transplant. N. Engl. J. Med. 1999; 341: 1725-1730.
2. Ponton P, Rupolo GP, Marchini F et al.,Quality of life change after kidney transplantation. Transplant Proc. 2001; 23: 1887-1889.
3. Cecka M. Clinical Outcome of Renal Transplantation: Factors influencing patient and Graft Survival. Surg. Clinics N. Amer. 1998; 78: 133-148.
4. Registry abstract
5. Cecka JM & Cho L. Sensitization. Clin. Transpl. 1988; 365-373.
6. Meier-Kriesche H, Port FK, Ojo AO et al., Deleterious effect of waiting time on renal transplant outcome. Transplant Proc. 2001 33: 1204-1206
7. Raftery MJ, Lang CJ, O'Shea JM et al. Controlled trial of azathioprine and cyclosporin to prevent anti-HLA antibodies due to third-party transfusion. Nephrol Dial Transplant 1988; 3: 671-675.
8. Niaudet P, Dudley J, Charbit M, Gagnadoux MF, Macleary K, Broyer M. Pretransplant blood transfusions with cyclosporine in paediatric renal transplantation. Paediatr Nephrol 2000; 14:451-456.
9. Papassavas AC, Iniotaki-Theodoraki A, Boletis J, Kostakis A, Stravropoulos-Giokas C. Epitoe analysis of HLA class I donor specific antibodies in sensitised renal transplant recipients. Transplantation 2000; 70: 323-327.
10. Opelz G, Gengar DP, Mickey MR & Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973; 5: 253-259.
11. Opelz G. Improved kidney graft survival in non-transfused recipients. Transplant Proc. 1987; 19: 149-152.
12. Flye MW, Burton K, Mohanakumar T et al. Donor-specific transfusions have long-term beneficial effects for human renal allografts. Transplantation 1995 60: 1395-401.
13. Opelz G, Vanrenterghem Y, Kirste, G et al. Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients. Transplantation 1997;63: 964-967.
14. Chavers BM, Sullivan EK, Tejani A, Harmon WE. Pre-transplant blood transfusion and renal allograft outcome: a report of the North American Paediatric Renal Transplant Cooperative Study. Pediatr Transplant 1997; 1: 22-28
15. Scornik JC, Saloman DR, Howard RJ, Pfaff WW. Prevention of transfusion induced broad sensitisation in renal transplant candidates. Transplantation 1989; 47: 617-620